Posted in | News | Medical Sensor

ams Expands Optical Sensor Portfolio with the Acquisition of CMOSIS

ams, a leading worldwide provider of high-performance sensor and analog solutions, has entered into an agreement to acquire 100% of the shares in CMOSIS, a leader in advanced area and line scan CMOS image sensors for high-end imaging applications, in an all-cash transaction.

CMOSIS, headquartered in Antwerp (Belgium), is a leading supplier of high performance standard and customized area and line scan CMOS image sensors for demanding imaging applications. CMOSIS’ portfolio of imaging solutions features low noise, global and rolling shutter, high dynamic range, and high frame rates through high-speed on-chip analog-to-digital conversion and digital interfaces. CMOSIS’ image sensors serve a broad range of high-end applications in diverse markets including machine vision, medical, broadcast, traffic, scientific and photographic imaging. In addition, CMOSIS offers the NanEye miniature camera module line for endoscopy-like medical applications, recently winning the German Innovation Award for Non-Clinical Intensive Care.

Founded in 2007, CMOSIS operates as a fabless semiconductor supplier from locations in Belgium, Germany, Portugal, and the U.S. and has more than 110 employees. CMOSIS expects to generate full year 2015 revenues of approx. EUR 60m with strong operating profitability above ams’ current group operating profitability. Based on available information, CMOSIS expects to continue year-on-year revenue growth in 2016.

Under the terms of the agreement, ams will acquire 100% of the shares in CMOSIS from TA Associates, a leading global growth private equity firm, and management shareholders for an equity value of approx. EUR 220m. ams expects to fund the transaction from existing cash and available credit lines with no additional transaction-based financing. The transaction is expected to close within the next six weeks subject to certain regulatory approvals and the occurrence of certain conditions defined in the agreements with the sellers of the CMOSIS shares.

“Acquiring CMOSIS is a highly complementary expansion of our sensor portfolio and another major step in executing our sensor solutions growth strategy. This transaction extends our market leadership in optical sensors and will strengthen our position as the leading pure-play sensor solutions provider for growth markets including Industry 4.0, IoT (Internet of Things) and medical diagnostics. Integrating cameras with advanced optical sensors will drive new sensor solutions across vertical markets and accelerate our growth plans as we combine CMOSIS’ leading edge IP and design capabilities with our manufacturing competence and optical sensor strengths”, emphasizes Kirk Laney, CEO of ams.

“CMOSIS has built a leading position in some of the most challenging imaging applications based on our deep technology expertise in CMOS area and line scan image sensors. Our team is at the forefront of global shutter technology for high-end imaging having up to more than 15 years of experience in this field. We are excited to join ams creating a leader in advanced imaging solutions. We will leverage ams’ technical and operational expertise and profit from the global access to potential new customers to realize our full growth potential”, adds Luc de Mey, CEO of CMOSIS.

Source: http://ams.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.